Hargreaves, IP, Mantle, D and Milford, D (2019) Chronic kidney disease and coenzyme Q10 supplementation. Journal of Kidney Care, 4 (2). pp. 82-90. ISSN 2397-9534
|
Text
Chronic kidney disease and coenzyme Q10 supplementation.pdf - Accepted Version Download (413kB) | Preview |
Abstract
Among the potential causes of chronic kidney disease (CKD), mitochondrial respiratory chain (MRC) dysfunction, oxidative stress and inflammation have been implicated as contributor factors to the pathogenesis of this disorder. It is thought that CoQ10 supplementation may offer some therapeutic potential in the treatment of patients with CKD, since CoQ10 has a key role in normal MRC function, as well as having antioxidant and anti-inflammatory action. This article will outline the current knowledge on the use of CoQ10 in the treatment of CKD
Item Type: | Article |
---|---|
Additional Information: | This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Kidney Care, copyright © MA Healthcare, after peer review and technical editing by the publisher. To access the final edited and published work see http://dx.doi.org/10.12968/jokc.2019.4.2.82 |
Subjects: | R Medicine > RM Therapeutics. Pharmacology |
Divisions: | Pharmacy & Biomolecular Sciences |
Publisher: | Mark Allen Group |
Date Deposited: | 02 Apr 2019 09:14 |
Last Modified: | 04 Sep 2021 09:32 |
DOI or ID number: | 10.12968/jokc.2019.4.2.82 |
URI: | https://researchonline.ljmu.ac.uk/id/eprint/10461 |
View Item |